gabapentin and amphetamine

gabapentin has been researched along with amphetamine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bossert, JM; Franklin, KB1
Bannon, AW; Decker, MW; Gauvin, D; Hsieh, GC; Joshi, SK; Lee, CH; Lewis, LG; Mikusa, J; Mills, CD; Rueter, LE; Zhong, C; Zhu, CZ1
Ceretta, APC; de Freitas, CM; Dotto, MM; Fachinetto, R; Reinheimer, JB; Schaffer, LF1
Andrade, L; Hyland, R; Johnson, C; Muñoz-Muñoz, AC; Pekol, T; Schubring, D1

Reviews

1 review(s) available for gabapentin and amphetamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for gabapentin and amphetamine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Reinforcing versus anticonvulsant drugs: effects on intracranial self-stimulation rate-frequency M50 indices.
    Behavioural brain research, 2003, Sep-15, Volume: 144, Issue:1-2

    Topics: Acetates; Amines; Amphetamine; Animals; Anticonvulsants; Central Nervous System Stimulants; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Interactions; Gabapentin; gamma-Aminobutyric Acid; Male; Medial Forebrain Bundle; Pentobarbital; Rats; Rats, Long-Evans; Reinforcement, Psychology; Self Stimulation

2003
Assessing carrageenan-induced locomotor activity impairment in rats: comparison with evoked endpoint of acute inflammatory pain.
    European journal of pain (London, England), 2012, Volume: 16, Issue:6

    Topics: Acute Pain; Adrenergic Uptake Inhibitors; Amines; Amphetamine; Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Carrageenan; Central Nervous System Stimulants; Cyclohexanecarboxylic Acids; Diclofenac; Disease Models, Animal; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Ibuprofen; Lameness, Animal; Male; Morphine; Motor Activity; Neuritis; Rats; Rats, Sprague-Dawley; Thiophenes

2012
Gabapentin prevents behavioral changes on the amphetamine-induced animal model of schizophrenia.
    Schizophrenia research, 2016, Volume: 175, Issue:1-3

    Topics: Amines; Amphetamine; Animals; Behavior, Animal; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Humans; Models, Animal; Rats, Sprague-Dawley; Schizophrenia

2016
Characterization of an Amphetamine Interference from Gabapentin in an LC-HRMS Method.
    Journal of analytical toxicology, 2020, Jan-07, Volume: 44, Issue:1

    Topics: Amphetamine; Chromatography, High Pressure Liquid; Chromatography, Liquid; Gabapentin; Humans

2020